Basis of Presentation and Summary of Significant Accounting Policies (Details Narrative) - USD ($) |
9 Months Ended | ||
|---|---|---|---|
Sep. 30, 2022 |
Sep. 30, 2021 |
Dec. 31, 2021 |
|
| Research And Development Expenses | $ 10,600,000 | $ 9,700,000 | |
| Deferred Revenue | 1,000,000.0 | ||
| Cash and cash equivalents | 1,640,000 | ||
| Amount held in money markey account | 1,020,000 | ||
| Accounts Receivable | $ 5,492 | $ 12,510 | |
| Warrants And Options [Member] | |||
| Potentially Dilutive Securities Excluded From The Computation Of Eps | 6,302,138 | ||
| X | ||||||||||
- Definition Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Details
|